Evidence map›Paper›PMID 33714056›Full record

ArticleDevelopmental cognitive neuroscience2021

12-Month peak alpha frequency is a correlate but not a longitudinal predictor of non-verbal cognitive abilities in infants at low and high risk for autism spectrum disorder.

Virginia Carter Leno, Andrew Pickles, Stefon van Noordt, Scott Huberty, James Desjardins, Sara Jane Webb, Mayada Elsabbagh, BASIS Team

Open access · goldAbstract read
In one paragraph

Article in Developmental cognitive neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. EEG neurosubtyping of infants predicts language trajectories.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Oxytocin treatment rescues irritability-like behavior in Cc2d1a conditional knockout mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Virginia Carter LenoInstitute of Psychiatry, Psychology & Neuroscience, King's College London, UK. Electronic address: virginia.carter_leno@kcl.ac.uk.
Andrew PicklesInstitute of Psychiatry, Psychology & Neuroscience, King's College London, UK.
Stefon van NoordtMontreal Neurological Institute, Azrieli Centre for Autism Research, McGill University, Montréal, Canada.
Scott HubertyMontreal Neurological Institute, Azrieli Centre for Autism Research, McGill University, Montréal, Canada.
James DesjardinsCompute Ontario, Canada.
Sara Jane WebbCenter on Child Health, Behavior and Development, Seattle Children's Research Institute, Seattle, WA, USA.
Mayada ElsabbaghMontreal Neurological Institute, Azrieli Centre for Autism Research, McGill University, Montréal, Canada.
BASIS Team
Montreal Neurological Institute and Hospital · CAKing's College London · GBCompute Canada · CASeattle Children's Hospital · US

Funding

The Autism Biomarkers Consortium for Clinical TrialsU19MH108206 · NIMH · YALE UNIVERSITY · PI MCPARTLAND, JAMES CHARLES · 2015 to 2024
$68.8M
UW Autism Center of ExcellenceP50HD055782 · NICHD · UNIVERSITY OF WASHINGTON · PI KING, BRYAN H · 2007 to 2011
$11.0M
Mechanisms of Brain Dysmorphology in MN1 C-Terminal Truncation Syndrome, a Novel Intellectual Developmental Disability Disorder P50HD103524 · NICHD · UNIVERSITY OF WASHINGTON · PI DANIEL DOHERTY · 2020 to 2026
$9.9M
NICHD NIH HHS P50 HD055782NICHD NIH HHS P50 HD103524NIMH NIH HHS U19 MH108206Wellcome TrustWellcome Trust 213608/Z/18/Z
6 · The paper itself

Abstract

Although studies of PAF in individuals with autism spectrum disorder (ASD) report group differences and associations with non-verbal cognitive ability, it is not known how PAF relates to familial risk for ASD, and whether similar associations with cognition in are present in infancy. Using a large multi-site prospective longitudinal dataset of infants with low and high familial risk for ASD, metrics of PAF at 12 months were extracted and growth curves estimated for cognitive development between 12-36 months. Analyses tested whether PAF 1) differs between low and high risk infants, 2) is associated with concurrent non-verbal/verbal cognitive ability and 3) predicts developmental change in non-verbal/verbal ability. Moderation of associations between PAF and cognitive ability by familial risk status was also tested. No differences in 12-month PAF were found between low and high risk infants. PAF was associated with concurrent non-verbal cognitive ability, but did not predict change in non-verbal cognitive over development. No associations were found between PAF and verbal ability, along with no evidence of moderation. PAF is not related to familial risk for ASD, and is a neural marker of concurrent non-verbal cognitive ability, but not verbal ability, in young infants at low and high risk for ASD.

Indexed as

Autism Spectrum DisorderCognitionBiomarkersHumansInfantProspective StudiesSiblingsBiomarkersAutism spectrum disorderCognitive developmentEEGInfant siblingsPeak alpha frequency

Identifiers

PMID33714056
PMCPMC7966984
OpenAlexW3134896918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.